References
- Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007;147:553–62.
- Mamori S, Higashida A, Kawara F, Ohnishi K, Takeda A, Senda E, Age-dependent eradication of Helicobacter pylori in Japanese patients. World J Gastroenterol 2010;16:4176–9.
- Spencer CM, Faulds D. Esomeprazole. Drugs 2000;60:321–9.
- Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid-related disorders. Drugs 2002;62:1503–38.
- Johnson TJ, Hedge DD. Esomeprazole. A clinical review. Am J Health Syst Pharm 2002;59:1333–9.
- Johnson DA. Review of esomeprazole in the treatment of acid disorders. Expert Opin Pharmacother 2003;4:253–64.
- Kale-Pradhan PB, Landry HK, Sypula WT. Esomeprazole for acid peptic disorders. Ann Pharmacother 2002;36:655–63.
- Gatta L, Perna F, Figura N, Ricci C, Holton J, D'Anna L, Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother 2003;51:439–42.
- Gisbert JP, Pajares JM. Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis. Dig Liver Dis 2004;36:253–9.